High Dose Rate Endorectal Brachytherapy as a Neoadjuvant Treatment for Patients with Resectable Rectal Cancer
- 30 November 2007
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 19 (9) , 701-705
- https://doi.org/10.1016/j.clon.2007.07.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: Technical aspectsBrachytherapy, 2005
- Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trialsThe Lancet, 2001
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Preoperative Radiotherapy for Resectable Rectal CancerJAMA, 2000
- Effect of a surgical training programme on outcome of rectal cancer in the County of StockholmThe Lancet, 2000
- T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyJournal of Gastrointestinal Surgery, 1999
- Changing strategy for rectal cancer is associated with improved outcomeBritish Journal of Surgery, 1999
- Rectal CancerArchives of Surgery, 1998
- Mesorectal excision for rectal cancerThe Lancet, 1993
- The ‘Holy Plane’ of Rectal SurgeryJournal of the Royal Society of Medicine, 1988